These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8525883)

  • 1. The colon and rectum as inductor sites for local and distant mucosal immunity.
    Haneberg B; Kendall D; Amerongen HM; Apter FM; Neutra MR
    Adv Exp Med Biol; 1995; 371A():107-9. PubMed ID: 8525883
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces.
    Haneberg B; Kendall D; Amerongen HM; Apter FM; Kraehenbuhl JP; Neutra MR
    Infect Immun; 1994 Jan; 62(1):15-23. PubMed ID: 8262621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
    Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
    J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and mucosal antibody responses to group B streptococci following immunization of the colonic-rectal mucosa.
    Hordnes K; Digranes A; Haugen IL; Helland DE; Ulstein M; Jonsson R; Haneberg B
    J Reprod Immunol; 1995 Mar; 28(3):247-62. PubMed ID: 7473434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of IgA and IgG antibodies in vaginal fluid, serum and saliva following immunization of genital and gut associated lymphoid tissue.
    Bergmeier LA; Tao L; Gearing AJ; Adams S; Lehner T
    Adv Exp Med Biol; 1995; 371B():1567-73. PubMed ID: 7502858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonic antigen administration induces significantly higher humoral levels of colonic and vaginal IgA, and serum IgG compared to oral administration.
    McConnell EL; Basit AW; Murdan S
    Vaccine; 2008 Jan; 26(5):639-46. PubMed ID: 18178292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compartmentalization within the common mucosal immune system.
    Moldoveanu Z; Russell MW; Wu HY; Huang WQ; Compans RW; Mestecky J
    Adv Exp Med Biol; 1995; 371A():97-101. PubMed ID: 8526027
    [No Abstract]   [Full Text] [Related]  

  • 8. Enteric mucosal antibodies to Escherichia coli O157:H7 in adult cattle.
    Bretschneider G; Berberov EM; Moxley RA
    Vet Rec; 2008 Aug; 163(7):218-9. PubMed ID: 18708656
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination.
    Eriksson K; Quiding-Järbrink M; Osek J; Möller A; Björk S; Holmgren J; Czerkinsky C
    Infect Immun; 1998 Dec; 66(12):5889-96. PubMed ID: 9826370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal vaccination strategies for women.
    Kozlowski PA; Cu-Uvin S; Neutra MR; Flanigan TP
    J Infect Dis; 1999 May; 179 Suppl 3():S493-8. PubMed ID: 10099127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans.
    Jertborn M; Nordström I; Kilander A; Czerkinsky C; Holmgren J
    Infect Immun; 2001 Jun; 69(6):4125-8. PubMed ID: 11349086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of specific IgA in faecal extracts and intestinal lavage fluid for monitoring of mucosal immune responses.
    Grewal HM; Karlsen TH; Vetvik H; Ahrén C; Gjessing HK; Sommerfelt H; Haneberg B
    J Immunol Methods; 2000 May; 239(1-2):53-62. PubMed ID: 10821947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin concentrations and antigen-specific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle.
    Lü FX; Ma Z; Rourke T; Srinivasan S; McChesney M; Miller CJ
    Infect Immun; 1999 Dec; 67(12):6321-8. PubMed ID: 10569744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
    Elson CO; Ealding W
    J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
    Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J
    J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral immunization against experimental cholera: the role of antigen form and antigen combinations in evoking protection.
    Pierce NF; Cray WC; Sacci JB; Craig JP; Germanier R; Fürer E
    Ann N Y Acad Sci; 1983 Jun; 409():724-33. PubMed ID: 6603186
    [No Abstract]   [Full Text] [Related]  

  • 17. CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA-isotype switching in Peyer's patches.
    Gärdby E; Lycke NY
    Eur J Immunol; 2000 Jul; 30(7):1861-71. PubMed ID: 10940875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
    Liang XP; Lamm ME; Nedrud JG
    J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating dendritic cells to optimize mucosal immunization protocols.
    Williamson E; Westrich GM; Viney JL
    J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunity to oral vaccines.
    Ferguson A; Sallam J
    Lancet; 1992 Jan; 339(8786):179. PubMed ID: 1346028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.